Will Indivior turn, or will it continue to retrace recent fall back to 223p November highs?

• The chart shows the Indivior price action since early December.
• Shares in a 2 week uptrend from 75.5p December lows; now at 115.1p.
• Shares -78% from 2018 highs; +47% from 2018 lows; -72% year-to-date.
• 18 Dec: Shares rally after the drug manufacturer reiterated its full-year guidance
• 18 Dec: Indivior said it has a contingency plan if a generic alternative to its drugs is introduced.
• In the past 2 weeks, the shares have risen over 25%. Will this momentum continue?
• Source: Bloomberg, FT, Reuters, DJ Newswires, AlphaTerminal

Click to enlarge

Trading Indivior – An Example

Let’s say the trend appeals to you, you think it’s likely to continue. You decide to buy exposure to £10,000 worth of Indivior using a CFD, at the current price of 115.1p. To do this, you need £2,000.

Let’s assume Indivior trend continues to November high of 223p (+93.7%). Your profit would be £9370, from your initial investment of £2,000.

Conversely, let’s assume you open the above position, and place a stop-loss at 9% from the current price. Indivior falls 9% and hits your stop-loss. Your loss would be £900.

This is provided for information purposes only. It should not be taken as a recommendation.